News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shacham Sharon
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/16/2022 |
4
| Shacham Sharon (Director) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Granted 35,235 options to buy
@ $12.5, valued at
$440.4k
|
|
| 03/31/2022 |
4
| Shacham Sharon (Chief Scientific Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 60,000 shares
@ $0
Granted 90,000 options to buy
@ $10.33, valued at
$929.7k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Shacham Sharon (Chief Scientific Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 6,707 shares
@ $9.862, valued at
$66.1k
Sold 6,764 shares
@ $9.862, valued at
$66.7k
|
|
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2020 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,500 shares
@ $14.891, valued at
$111.7k
Exercised 1,424 options to buy
@ $0.033, valued at
$47
Exercised 6,076 options to buy
@ $0.033, valued at
$200.5 |
|
| 08/18/2020 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 1,477 shares
@ $15, valued at
$22.2k
Exercised 1,477 options to buy
@ $0.033, valued at
$48.7 |
|
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,500 shares
@ $20, valued at
$150k
Exercised 7,500 options to buy
@ $0.033, valued at
$247.5 |
|
| 06/17/2020 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,143 shares
@ $16.3791, valued at
$117k
Sold 357 shares
@ $16.2, valued at
$5.8k
Exercised 7,143 options to buy
@ $0.033, valued at
$235.7
Exercised 357 options to buy
@ $0.033, valued at
$11.8 |
|
| 06/11/2020 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,500 shares
@ $18.4994, valued at
$138.7k
Sold 7,500 shares
@ $18.1259, valued at
$135.9k
Exercised 7,500 options to buy
@ $4.752, valued at
$35.6k
Exercised 7,500 options to buy
@ $4.752, valued at
$35.6k
|
|
| 05/19/2020 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,500 shares
@ $18.6454, valued at
$139.8k
Sold 7,500 shares
@ $20, valued at
$150k
Exercised 7,500 options to buy
@ $0.033, valued at
$247.5
Exercised 7,500 options to buy
@ $0.033, valued at
$247.5 |
|
| 05/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/10/2020 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 10,000 shares
@ $18.6115, valued at
$186.1k
Sold 10,000 shares
@ $20.6404, valued at
$206.4k
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 153,500 options to buy
@ $18, valued at
$2.8M
Granted 153,500 options to buy
@ $18, valued at
$2.8M
Granted 57,200 restricted stock units
@ $0
Granted 57,200 restricted stock units
@ $0 |
|
| 01/10/2020 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 10,000 shares
@ $18.5705, valued at
$185.7k
Sold 10,000 shares
@ $19.188, valued at
$191.9k
Gifted 17,313 shares
@ $0
Gifted 17,313 shares
@ $0
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
|
|
| 12/11/2019 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 10,000 shares
@ $17.021, valued at
$170.2k
Sold 10,000 shares
@ $15.9896, valued at
$159.9k
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2019 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 10,000 shares
@ $12, valued at
$120k
Sold 10,000 shares
@ $12, valued at
$120k
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
|
|
| 09/17/2019 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 10,000 shares
@ $12, valued at
$120k
Sold 10,000 shares
@ $12, valued at
$120k
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
Exercised 10,000 options to buy
@ $4.752, valued at
$47.5k
|
|
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2019 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 12,500 shares
@ $10.2259, valued at
$127.8k
Exercised 12,500 options to buy
@ $0.033, valued at
$412.5 |
|
| 12/10/2018 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 12,500 shares
@ $10.1138, valued at
$126.4k
Exercised 12,500 options to buy
@ $0.033, valued at
$412.5 |
|
| 11/27/2018 |
4
| Shacham Sharon (President & CSO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 9,600 shares
@ $11, valued at
$105.6k
Exercised 9,600 options to buy
@ $4.752, valued at
$45.6k
|
|
|
|
|